Ab initio calculation of the interaction energy in the P2 binding pocket of HIV-1 protease

被引:8
|
作者
Nivesanond, K
Peeters, A
Lamoen, D
Van Alsenoy, C
机构
[1] Univ Antwerp, Dept Chem, B-2610 Antwerp, Belgium
[2] Tibotec BVBA, B-2800 Mechelen, Belgium
[3] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium
关键词
ab initio calculations; electrostatic potential map; HIV-1; protease; inhibitors; interaction energy; stockholder charges;
D O I
10.1002/qua.20724
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Interactions at the P2 binding pocket of human immunodeficiency virus type 1 (HIV-1) protease have been studied using calculated interaction energies for model systems that mimic this binding pocket. Models were built for the P2 pocket of HIV-1 protease in complex with TMC114, nelfinavir, and amprenavir. A two-step procedure was applied. In the first step, the size of the model system was confined to similar to 40 atoms, and the interaction energy was calculated at different computational levels. In the second step, the size of the system was increased to 138 atoms, and the calculations were only performed at the HF/6-31G** level. The interaction energy of the HIV-1 protease/TMC114 complex was found to be more favorable than the interaction energies of the other complexes because of the additional hydrogen bond interaction this inhibitor is able to make with the HIV-1 protease backbone. The results of the calculations are supported by stockholder charges and electrostatic potential maps. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [41] Influence of inhibitor binding on HIV-1 protease dynamics
    Ringhofer, S
    Dutzler, R
    Kallen, J
    Andrew, P
    Visser, A
    Billich, A
    Scholz, D
    Gstach, H
    Steinhauser, O
    Schreiber, H
    Auer, M
    Kungl, A
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 65 : PA309 - PA309
  • [42] Potent cyclic urea HIV protease inhibitors with indazole P2/P2' groups.
    Rodgers, JD
    Wang, HS
    Johnson, BL
    Lam, PY
    Ru, Y
    DeLucca, GV
    Kim, UT
    Ko, SS
    Trainor, GL
    Klabe, RM
    Cordova, BC
    Bacheler, LT
    EricksonViitanen, S
    Lam, GN
    Chang, CH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 144 - MEDI
  • [43] AB-INITIO CALCULATION OF THE HE(2(1)S)+H-2 INTERACTION
    BEVSEK, HM
    FALCETTA, MF
    SISKA, PE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 210 - PHYS
  • [44] Design and Evaluation of Novel HIV-1 Protease Inhibitors Containing Phenols or Polyphenols as P2 Ligands with High Activity against DRV-Resistant HIV-1 Variants
    Ma, Ling
    Wen, Jiajia
    Dong, Biao
    Zhou, Jinming
    Hu, Shangjiu
    Wang, Juxian
    Wang, Yucheng
    Zhu, Mei
    Cen, Shan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [45] HIV-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic and various P2/P1′ substituents
    Ohrngren, Per
    Wu, Xiongyu
    Ekegren, Jenny K.
    Unge, Torsten
    Rosenquist, Asa
    Samuelsson, Bertil
    Larhed, Mats
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [46] Design, synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1′ ligand
    Dou, Yue
    Zhu, Mei
    Dong, Biao
    Wang, Ju-Xian
    Zhang, Guo-Ning
    Zhang, Fan
    Wang, Yu-Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (07)
  • [47] Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes
    Lu, Yipin
    Yang, Chao-Yie
    Wang, Shaomeng
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (36) : 11830 - 11839
  • [48] Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation
    Ghosh, Arun K.
    Williams, Jacqueline N.
    Kovela, Satish
    Takayama, Jun
    Simpson, Hannah M.
    Walters, D. Eric
    Hattori, Shin-ichiro
    Aoki, Manabu
    Mitsuya, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (18) : 2565 - 2570
  • [49] Allophenylnorstatine containing HIV-1 protease inhibitors: design, synthesis and structure-activity relationships for selected P2 ligands
    Abdel-Rahman, HMM
    Matsumoto, H
    Bekhit, AA
    Mimoto, T
    Nojima, S
    Takaku, H
    Kimura, T
    Akaji, K
    Kiso, Y
    PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 662 - 664
  • [50] Predicting drug resistance of the HIV-1 protease using molecular interaction energy components
    Hou, Tingjun
    Zhang, Wei
    Wang, Jian
    Wang, Wei
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2009, 74 (04) : 837 - 846